Clot Management Devices: Global Strategic Business Report

Quick Summary:

In the intricately networked global healthcare industry, the market for Clot Management Devices is anticipated to reach a value of US$2.6 Billion by 2030. This report provides an in-depth analysis of the industry, offering vital insights into its evolving landscape. The report forecasts market trends, segment growth, competitive landscapes, offering a clear pathway for strategic decisions aiding in sustained business growth.

The report extends special attention to segment-wise growths. Percutaneous Thrombectomy Devices lead the way with a projected CAGR of 4.8%, closely followed by Catheter-Directed Thrombolysis (CDT) Devices with revised 4.1% CAGR over the next 8 years. Geographic insights including the U.S and China, topped with growth forecasts of key economies such as Japan, Canada, and Germany, are thoroughly analyzed. Complemented with the competitive analysis of key market players, the report equips executives with crucial data to navigate the competitive terrain of the Clot Management Devices market.

Global Clot Management Devices Market to Reach $2.6 Billion by 2030

The global market for Clot Management Devices estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$2.6 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2022-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$999.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Catheter-Directed Thrombolysis (CDT) Devices segment is readjusted to a revised 4.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $549.5 Million, While China is Forecast to Grow at 4.4% CAGR

The Clot Management Devices market in the U.S. is estimated at US$549.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$463.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 11 Featured) -

Boston Scientific Corporation
Cook Medical LLC
DePuy Synthes
Edwards Lifesciences Corporation
iVascular S.L.U
LeMaitre Vascular, Inc.
Medtronic PLC
Straub Medical AG
Teleflex Inc.
Vascular Solutions, Inc.

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for Clot Management Devices

What is the estimated value of the Global Market for Clot Management Devices?

The Global Market for Clot Management Devices was estimated to be valued at $1.8 Billion in 2022.

What is the growth rate of the Global Market for Clot Management Devices?

The growth rate of the Global Market for Clot Management Devices is 4.7%, with an estimated value of $2.6 Billion by 2030.

What is the forecasted size of the Global Market for Clot Management Devices?

The Global Market for Clot Management Devices is estimated to be worth $2.6 Billion by 2030.

Who are the key companies in the Global Market for Clot Management Devices?

Key companies in the Global Market for Clot Management Devices include Boston Scientific Corporation, Cook Medical LLC, DePuy Synthes, Edwards Lifesciences Corporation, iVascular S.L.U, LeMaitre Vascular, Inc., Medtronic PLC, Straub Medical AG, Teleflex Inc. and Vascular Solutions, Inc..

Report Attribute	Details
No. of Pages	179
Published	September 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 1.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.6 Billion
Compound Annual Growth Rate	4.7%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Clot Management Devices - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 24: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 25: World Clot Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 27: USA Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 28: USA 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 29: USA Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 30: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: USA 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

CANADA

Table 32: Canada Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Canada Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 34: Canada 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 35: Canada Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 36: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: Canada 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

JAPAN

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 38: Japan Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 39: Japan Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: Japan 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 41: Japan Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 42: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 43: Japan 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

CHINA

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 44: China Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 45: China Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 46: China 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 47: China Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 48: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: China 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

EUROPE

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 50: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 51: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 52: Europe 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 53: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 54: Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 55: Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 56: Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 57: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

FRANCE

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 59: France Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 60: France Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 61: France 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 62: France Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 63: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 64: France 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

GERMANY

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 65: Germany Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 66: Germany Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 67: Germany 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 68: Germany Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 69: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 70: Germany 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

ITALY

Table 71: Italy Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 72: Italy Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 73: Italy 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 74: Italy Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 75: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: Italy 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

UNITED KINGDOM

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 77: UK Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 78: UK Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 79: UK 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 80: UK Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 81: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 82: UK 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

REST OF EUROPE

Table 83: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 84: Rest of Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 85: Rest of Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 86: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 87: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: Rest of Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

ASIA-PACIFIC

Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 90: Asia-Pacific Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 91: Asia-Pacific 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 93: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 94: Asia-Pacific 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

REST OF WORLD

Table 95: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 96: Rest of World Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 97: Rest of World 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2023 & 2030
Table 98: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
Table 99: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 100: Rest of World 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2023 & 2030

IV. COMPETITION